Winning combination for Roche
Pf speaks to Roche’s Pf Awards 2019 winners, Emma Reynolds who won the Secondary Care Specialist Pf Award 2019 and Julie Van Es who...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...
Building trust in health with sales representatives
Paul Terry explores how the sales representative is best placed to build trust with the health sector, and how industry needs to adapt to...
Dare to think rare
Dr Lucy McKay is Chief Executive of Medics4RareDiseases, a UK registered charity which is driving attitude change towards rare diseases in the medical profession...
Agencies and the ABPI code of practice
Rina Newton shares her top tips for ensuring agencies comply with the ABPI Code of Practice. Agencies are engaged by pharmaceutical companies because the expertise...
Stand up and be proud: Kyowa Kirin and the Pf Awards
Dan Davies shares Kyowa Kirin’s motivation for entering and sponsoring the Pf Awards. What is Kyowa Kirin? Kyowa Kirin is a highly successful and rapidly growing...
A guide to implementing Agile in pharma
Following his article on Agile and its role in addressing pharma’s productivity problems, Neil Osmond shares his guide to implementing Agile in pharma. If you’ve...
Developing product and patient centric services
What are the trends shaping the successful delivery of patient centric services? The pharmaceutical industry is evolving rapidly and as times change, so do the...
Collaboration is the key to innovation in pharma
Enterprise Europe Network explains how collaboration is the key to innovation in pharma and how businesses should collaborate to grow. Successful business in the pharmaceutical...
Back on track – what’s next for ISO IDMP?
A series of delays may have sapped momentum, but it was never in doubt that the European Medicines Agency would deliver ISO IDMP. Now,...
Latest articles
Drug firms admit to colluding to keep up prices of antidepressants
Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...
Licensing status of Avastin updated by MHRA
The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Licensing status of Avastin updated by MHRA
The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Poor diabetes control costs the NHS £3bn in avoidable treatment
New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s...
Drug firms admit to colluding to keep up prices of antidepressants
Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...